US tariffs on patented pharma imports bring mixed impact for India, protecting generics but raising long-term risks for supply chains and investments.
Emami has signed a deal to acquire full stake in Axiom Ayurveda, marking its entry into the fast-growing health and wellness beverage segment.
India bioeconomy growth stands at USD 165.7 billion based on the latest government data, driven by biotech startups, policy support, and manufacturing push, strengthening its role in economic expansion.
Bayer simplifies access to Eylea 2mg in India, enabling early treatment for retinal diseases like Wet AMD and DME, improving patient access and reducing cost barriers.
Alkem Strengthens Ujjain Expansion as Alkem Laboratories on Thursday announced it will nearly double its investment to Rs 1,036 crore for a greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh.
Emcure Pharmaceuticals has sharply cut the price of its weight loss drug Poviztra across India, slashing costs by an average of 47% to make the semaglutide based treatment more affordable for patients.The reduced pricing takes effect from April 3,
The Punjab government is rapidly improving Healthcare Scheme Access through the Mukh Mantri Sehat Yojna, with ASHA workers taking the lead in enrolments across the state.
Alembic Pharmaceuticals Limited has entered into a strategic partnership with Enthral.ai to roll out an advanced AI-powered skilling platform, marking a major step in modernizing its training ecosystem.
ZEISS India has launched its new ClearMind lenses today, bringing a fresh approach to everyday vision. The ClearMind lenses are designed to deliver sharper clarity while reducing the cognitive load caused by blurry vision, making them ideal for...
Biogen said it will acquire Apellis Pharmaceuticals for USD 5.6 billion, marking a major step in its rare disease strategy. The Biogen to buy Apellis deal comes as the company looks to reduce reliance on its aging multiple sclerosis portfolio and...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")